Cargando…
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/ https://www.ncbi.nlm.nih.gov/pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 |
| _version_ | 1784887562812260352 |
|---|---|
| author | Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios |
| author_facet | Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios |
| author_sort | Pardo-Cabello, Alfredo Jose |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9922576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99225762023-02-13 Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2023-06 2023-02-13 /pmc/articles/PMC9922576/ /pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 Text en © 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
| title | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
| title_full | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
| title_fullStr | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
| title_full_unstemmed | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
| title_short | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
| title_sort | safety of covid-19 vaccines: a comparison between adverse drug reactions among vaccines marketed in europe |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/ https://www.ncbi.nlm.nih.gov/pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 |
| work_keys_str_mv | AT pardocabelloalfredojose safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope AT manzanogamerovictoria safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope AT lunajuandedios safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope |